Explore the latest strategies for selecting treatment regimens in HER2-positive breast cancer, focusing on safety and patient-specific factors. Under current NCCN guidelines as of mid-December 2025, ...
Waveshare ESP32-S3-RLCD-4.2 is a 4.2-inch Reflective LCD (RLCD) development board built around ESP32-S3 wireless SoC for DIY projects, rapid prototyping, and smart display devices that need a ...
An oscilloscope is usually the most sensitive, and arguably most versatile, tool on a hacker’s workbench, often taking billions of samples per second to produce an accurate and informative ...
Low-power Analog-to-Digital Converters (ADCs) are critical for energy-constrained applications such as portable and biomedical systems. However, the input buffers required to drive large ADC sampling ...
Antibody-drug conjugates (ADCs) are a mature technology. The first ADC, Mylotarg, was initially approved in 2000, and there are now 14 approved agents in both leukemias and solid tumors. According to ...
Neutropenia, anemia, and thrombocytopenia are common hematologic toxicities associated with ADCs. The most common cytopenia associated with T-DXd is neutropenia. In the DESTINY-Breast03 trial, ...
Antibody-drug conjugates (ADCs) have revolutionized the oncology field, offering targeted cancer treatments that improve efficacy without adversely affecting healthy cells. 1 ADCs’ potential extends ...
The pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects. There is still more work to be done to refine ...
ADC Engineering in Hanahan has announced the addition of Hannah McKool, SE, and Jeremy Williams, PE, to its structural engineering department. McKool joins the firm’s Charleston office as a project ...
NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Medicovestor, Inc., a biotechnology company advancing next-generation antibody-drug conjugates (ADCs), announced today that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results